WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released the following statement today in response to a misleading segment on the cost of innovative cancer therapies on this week’s 60 Minutes. The following statement may be attributed to BIO President and CEO Jim Greenwood:
“It is unfortunate that CBS has chosen to attack the price of specialty cancer medications while ignoring the value created by these drugs for patients and the healthcare system. Cancer patients today are able to live longer and enjoy a higher quality of life than ever before thanks to medicines made by biopharmaceutical research companies.
Help employers find you! Check out all the jobs and post your resume.
